Holders · period archive

DRUG · Bright Minds Biosciences Inc.

Q4 2023 13F holders

← latest ownership dossier

Ticker: DRUG
Type: Equity
Class: COM NEW
Total reported value ($000, long equity)

Manager	Report date	Value	Shares